AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Clinical Trials as TopicClinical Trials, Phase I as TopicTreatment OutcomeClinical Trials, Phase III as TopicClinical Trials, Phase II as TopicNeoplasmsMaximum Tolerated DoseDrug Administration ScheduleResearch DesignDouble-Blind MethodDrug EvaluationAntineoplastic AgentsControlled Clinical Trials as TopicDose-Response Relationship, DrugAntineoplastic Combined Chemotherapy ProtocolsInfusions, IntravenousPatient SelectionRandomized Controlled Trials as TopicTime FactorsMulticenter Studies as TopicPlacebosAdministration, OralFollow-Up StudiesClinical Trials Data Monitoring CommitteesProspective StudiesClinical ProtocolsCombined Modality TherapyClinical Trials, Phase IV as TopicCoxiellaSingle-Blind MethodArea Under CurveMetabolic Detoxication, Phase IEarly Termination of Clinical TrialsNauseaDrug Therapy, CombinationPaclitaxelPilot ProjectsFeasibility StudiesNeutropeniaSample SizeResearch SubjectsSurvival AnalysisAntibodies, MonoclonalQuality of LifeEndpoint DeterminationLung NeoplasmsDeoxycytidineUnited StatesDrugs, InvestigationalCamptothecinBreast NeoplasmsAntineoplastic Agents, PhytogenicThrombocytopeniaDisease-Free SurvivalSeverity of Illness IndexRecurrenceSurvival RateInformed ConsentFluorouracilOutcome Assessment (Health Care)Antibodies, Monoclonal, HumanizedVomitingDisease ProgressionCisplatinCost-Benefit AnalysisTaxoidsEvidence-Based MedicineMedical OncologyNeoplasm StagingPrognosisCancer VaccinesDrug CombinationsQuestionnairesPatient ComplianceDrug-Related Side Effects and Adverse ReactionsReproducibility of ResultsRisk FactorsNontherapeutic Human ExperimentationFatigueTherapeutic Human ExperimentationMetabolic Clearance RatePatient ParticipationCross-Over StudiesBiomedical ResearchSafetyCarboplatinTopotecanNeoplasm Recurrence, LocalNeoplasm MetastasisRisk AssessmentImmunotherapyPlacebo EffectQuinazolinesDietary SupplementsData Interpretation, StatisticalDoxorubicinMelanomaCarcinoma, Non-Small-Cell LungAntimetabolites, AntineoplasticPain Measurement